Daniel Chappard

13.9k total citations
354 papers, 11.1k citations indexed

About

Daniel Chappard is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Daniel Chappard has authored 354 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Orthopedics and Sports Medicine, 106 papers in Oncology and 93 papers in Molecular Biology. Recurrent topics in Daniel Chappard's work include Bone health and treatments (99 papers), Bone health and osteoporosis research (91 papers) and Bone Tissue Engineering Materials (65 papers). Daniel Chappard is often cited by papers focused on Bone health and treatments (99 papers), Bone health and osteoporosis research (91 papers) and Bone Tissue Engineering Materials (65 papers). Daniel Chappard collaborates with scholars based in France, United Kingdom and Romania. Daniel Chappard's co-authors include M.F. Baslé, Guillaume Mabilleau, Maurice Audran, Érick Legrand, C. Alexandre, A. Mieczkowska, Hélène Libouban, G Riffat, Régis Bataille and R. Filmon and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Daniel Chappard

339 papers receiving 10.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Daniel Chappard 2.8k 2.8k 2.5k 2.4k 2.2k 354 11.1k
Peter V. Hauschka 4.4k 1.6× 1.3k 0.5× 1.9k 0.8× 1.5k 0.6× 990 0.5× 102 10.9k
David M. Findlay 6.1k 2.2× 2.1k 0.8× 3.3k 1.3× 1.7k 0.7× 2.1k 1.0× 282 13.3k
Pierre J. Marie 7.7k 2.8× 2.8k 1.0× 3.6k 1.4× 3.3k 1.4× 2.2k 1.0× 279 16.0k
Moustapha Kassem 10.5k 3.8× 2.5k 0.9× 3.7k 1.5× 2.8k 1.1× 3.7k 1.7× 361 21.6k
Louis C. Gerstenfeld 6.1k 2.2× 2.4k 0.9× 2.3k 0.9× 2.6k 1.1× 3.2k 1.5× 149 14.0k
Marc D. Grynpas 2.7k 1.0× 2.5k 0.9× 1.4k 0.6× 3.0k 1.3× 2.3k 1.1× 274 12.1k
J. Dequeker 2.6k 0.9× 6.8k 2.4× 2.7k 1.1× 1.4k 0.6× 3.5k 1.6× 267 12.9k
Stephen B. Doty 2.6k 0.9× 2.3k 0.8× 996 0.4× 2.1k 0.8× 2.3k 1.1× 161 9.4k
Marc D. McKee 6.5k 2.3× 2.5k 0.9× 2.0k 0.8× 3.2k 1.3× 2.2k 1.0× 238 21.0k
B.L. Clarke 3.4k 1.2× 4.4k 1.6× 3.6k 1.4× 861 0.4× 3.7k 1.7× 297 13.3k

Countries citing papers authored by Daniel Chappard

Since Specialization
Citations

This map shows the geographic impact of Daniel Chappard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Chappard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Chappard more than expected).

Fields of papers citing papers by Daniel Chappard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Chappard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Chappard. The network helps show where Daniel Chappard may publish in the future.

Co-authorship network of co-authors of Daniel Chappard

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Chappard. A scholar is included among the top collaborators of Daniel Chappard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Chappard. Daniel Chappard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouvard, Béatrice, Johanne Agerlin Windeløv, Norio Harada, et al.. (2020). Enteroendocrine K Cells Exert Complementary Effects to Control Bone Quality and Mass in Mice. Journal of Bone and Mineral Research. 35(7). 1363–1374. 14 indexed citations
2.
3.
Mieczkowska, A., et al.. (2019). GIP analogues augment bone strength by modulating bone composition in diet-induced obesity in mice. Peptides. 125. 170207–170207. 24 indexed citations
4.
Kahn, A, Jean‐Daniel Kün‐Darbois, Hélios Bertin, Pierre Corre, & Daniel Chappard. (2019). Mandibular bone effects of botulinum toxin injections in masticatory muscles in adult. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 129(2). 100–108. 23 indexed citations
5.
Ominsky, Michael S., Jean‐Pierre Devogelaer, Daniel Chappard, et al.. (2019). Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta. Bone. 124. 137–147. 35 indexed citations
6.
Chappard, Daniel, et al.. (2018). Metaplastic woven bone in bone metastases: A Fourier-transform infrared analysis and imaging of bone quality (FTIR). Morphologie. 102(337). 69–77. 4 indexed citations
7.
Mieczkowska, A., et al.. (2018). Sitagliptin Alters Bone Composition in High-Fat-Fed Mice. Calcified Tissue International. 104(4). 437–448. 21 indexed citations
8.
Mabilleau, Guillaume, Rodolphe Perrot, A. Mieczkowska, et al.. (2016). Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption. Bone. 91. 102–112. 37 indexed citations
9.
Mabilleau, Guillaume, Rodolphe Perrot, Peter R. Flatt, Nigel Irwin, & Daniel Chappard. (2016). High fat-fed diabetic mice present with profound alterations of the osteocyte network. Bone. 90. 99–106. 37 indexed citations
10.
Mieczkowska, A., Peter R. Flatt, Béatrice Bouvard, et al.. (2016). A new stable GIP–Oxyntomodulin hybrid peptide improved bone strength both at the organ and tissue levels in genetically-inherited type 2 diabetes mellitus. Bone. 87. 102–113. 31 indexed citations
11.
Libouban, Hélène, et al.. (2016). In vivo erosion of orthopedic screws prepared from nacre (mother of pearl). Orthopaedics & Traumatology Surgery & Research. 102(7). 913–918. 7 indexed citations
12.
Mabilleau, Guillaume, A. Mieczkowska, Nigel Irwin, Peter R. Flatt, & Daniel Chappard. (2013). Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor. Journal of Endocrinology. 219(1). 59–68. 89 indexed citations
13.
Koufany, Meriem, Daniel Chappard, Patrick Netter, et al.. (2013). The Peroxisome Proliferator–Activated Receptor γ Agonist Pioglitazone Preserves Bone Microarchitecture in Experimental Arthritis by Reducing the Interleukin‐17–Dependent Osteoclastogenic Pathway. Arthritis & Rheumatism. 65(12). 3084–3095. 13 indexed citations
14.
Mabilleau, Guillaume, Daniel Chappard, & Michel‐Félix Baslé. (2011). Cellular and molecular effects of thiazolidinediones on bone cells: a review. HAL (Le Centre pour la Communication Scientifique Directe). 4 indexed citations
15.
Idris, Aymen I., et al.. (2009). Pharmacologic inhibitors of IκB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo. Molecular Cancer Therapeutics. 8(8). 2339–2347. 85 indexed citations
16.
Zaharia, Cătălin, et al.. (2006). New hema-based polymeric microbeads for drug delivery systems. 1 indexed citations
17.
Audran, Maurice, Érick Legrand, Daniel Chappard, Jean‐Claude Bigorgne, & Michel‐Félix Baslé. (2000). Ostéoporose chez l'homme.. 151(5). 399–407. 1 indexed citations
18.
Monthéard, Jean‐Pierre, Michel Chatzopoulos, & Daniel Chappard. (1992). 2-Hydroxyethyl Methacrylate (HEMA): Chemical Properties and Applications in Biomedical Fields. Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics. 32(1). 1–34. 350 indexed citations
19.
Chappard, Daniel, et al.. (1989). Cytomorphometry of osteoclasts.. PubMed. 46(4). 363–6. 12 indexed citations
20.
Vico, Laurence, et al.. (1987). [Quantitative histological study of the bone mass and cellular activity after 120-days decubitus. Trial of preventive protocols].. PubMed. 45(2). 145–51. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter V. Hauschka Breakdown of academic impact, for papers by David M. Findlay Breakdown of academic impact, for papers by Pierre J. Marie Breakdown of academic impact, for papers by Moustapha Kassem Breakdown of academic impact, for papers by Louis C. Gerstenfeld Breakdown of academic impact, for papers by Marc D. Grynpas Breakdown of academic impact, for papers by J. Dequeker Breakdown of academic impact, for papers by Stephen B. Doty Breakdown of academic impact, for papers by Marc D. McKee Breakdown of academic impact, for papers by B.L. Clarke
Rankless by CCL
2026